Publications
Detailed Information
Directed evolution of CRISPR-Cas9 to increase its specificity
Cited 314 time in
Web of Science
Cited 330 time in Scopus
- Authors
- Issue Date
- 2018-08-06
- Publisher
- Nature Publishing Group
- Citation
- Nature Communications, Vol.9, p. 3048
- Abstract
- The use of CRISPR-Cas9 as a therapeutic reagent is hampered by its off-target effects. Although rationally designed S. pyogenes Cas9 (SpCas9) variants that display higher specificities than the wild-type SpCas9 protein are available, these attenuated Cas9 variants are often poorly efficient in human cells. Here, we develop a directed evolution approach in E. coli to obtain Sniper-Cas9, which shows high specificities without killing on-target activities in human cells. Unlike other engineered Cas9 variants, Sniper-Cas9 shows WT-level on-target activities with extended or truncated sgRNAs with further reduced off-target activities and works well in a preassembled ribonucleoprotein (RNP) format to allow DNA-free genome editing.
- ISSN
- 2041-1723
- Files in This Item:
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.